Mineralys Therapeutics (MLYS) Treasury Shares (2022 - 2025)

Mineralys Therapeutics has disclosed Treasury Shares across 4 years of filings, most recently posting $125793.0 for Q4 2025.

• Treasury Shares for Q4 2025 came in at $125793.0, down 66.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $125793.0 (down 66.01% YoY), and the FY2025 annual result was $125793.0, down 66.01% from the prior year.
• Treasury Shares came in at $125793.0 for Q4 2025 at Mineralys Therapeutics, down from $370106.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.2 million in Q4 2022 to a low of $125793.0 in Q4 2025.
• The 4-year median for Treasury Shares is $689018.0 (2023), against an average of $675741.2.
• Across the five-year window, Treasury Shares declined 15.95% in 2023 and tumbled 66.01% in 2025, its largest moves.
• Mineralys Therapeutics' Treasury Shares stood at $1.2 million in 2022, then slipped by 15.95% to $1.0 million in 2023, then slumped by 63.28% to $370106.0 in 2024, then sank by 66.01% to $125793.0 in 2025.
• The last three Treasury Shares figures came in at $125793.0 (Q4 2025), $370106.0 (Q4 2024), and $1.0 million (Q4 2023), per Business Quant data.